https://www.openbell.ai/ 2026-10-15T21:37:57.742Z hourly 1.0 https://www.openbell.ai/support 2026-10-15T21:37:57.742Z monthly 0.7 https://www.openbell.ai/privacy 2026-10-15T21:37:57.742Z monthly 0.5 https://www.openbell.ai/terms 2026-10-15T21:37:57.742Z monthly 0.5 https://www.openbell.ai/feed.json 2026-10-15T21:37:57.742Z hourly 0.8 https://www.openbell.ai/news/SLDB:1792099732757 2026-10-15T21:28:52.757Z daily 0.9 https://cdn.brandfetch.io/SLDB/w/400/h/400?c=1idopYfmtR7ZKg8QMud UBS Initiates Coverage On Solid Biosciences with Buy Rating, Announces Price Target of $20 UBS analyst Joon Lee has initiated coverage on Solid Biosciences (NASDAQ: SLDB) with a Buy rating. The firm has set a price target of $20 for the company's stock. https://www.openbell.ai/news/REGN:1792099385593 2026-10-15T21:23:05.593Z daily 0.9 https://cdn.brandfetch.io/REGN/w/400/h/400?c=1idopYfmtR7ZKg8QMud UBS Upgrades Regeneron Pharmaceuticals to Buy, Raises Price Target to $978 UBS analyst Trung Huynh has upgraded Regeneron Pharmaceuticals (NASDAQ: REGN) from Neutral to Buy. The price target for the stock has been raised significantly from $660 to $978. https://www.openbell.ai/news/COST:1792099092193 2026-10-15T21:18:12.193Z daily 0.9 https://cdn.brandfetch.io/COST/w/400/h/400?c=1idopYfmtR7ZKg8QMud Tigress Financial Maintains Buy on Costco Wholesale, Raises Price Target to $1250 Tigress Financial analyst Ivan Feinseth has maintained a Buy rating on Costco Wholesale (NASDAQ: COST) and raised the price target from $1,065 to $1,250. This adjustment reflects the firm's positive outlook on the company's performance. https://www.openbell.ai/news/GOOGL:1792098427925 2026-10-15T21:07:07.925Z daily 0.9 https://cdn.brandfetch.io/GOOGL/w/400/h/400?c=1idopYfmtR7ZKg8QMud 'Investors temper Anthropic IPO valuation expectations over revenue growth slowdown, sources say'- Reuters Exclusive Investors are adjusting their expectations for Anthropic's upcoming IPO valuation due to a reported slowdown in revenue growth. This shift comes as concerns grow over the company's financial performance, impacting investor sentiment. The article highlights the potential implications for the stock market, particularly for related entities such as Alphabet Inc. (GOOGL). https://www.openbell.ai/news/FRTT:1792098349692 2026-10-15T21:05:49.692Z daily 0.9 https://cdn.benzinga.com/files/images/story/2025/11/06/movers_3.jpg?width=250&height=187 12 Consumer Discretionary Stocks Moving In Thursday's After-Market Session In Thursday's after-market session, Fort Technology (NASDAQ:FRTT) saw its stock rise by 13.9% to $0.68, with a market value of $10.4 million. Other notable gainers included Interactive Strength (NASDAQ:TRNR), which increased by 9.83% to $2.01, and Skillful Craftsman (NASDAQ:EDTK), up 6.44% to $0.99. Conversely, Ping An Biomedical (NASDAQ:PASW) experienced the largest decline, falling 11.3% to $0.12, while MKDWell Tech (NASDAQ:MKDW) dropped 9.98% to $0.78. https://www.openbell.ai/news/TCRT:1792098349453 2026-10-15T21:05:49.453Z daily 0.9 https://cdn.benzinga.com/files/images/story/2025/11/06/movers_3.jpg?width=250&height=187 12 Health Care Stocks Moving In Thursday's After-Market Session In Thursday's after-market session, Alaunos Therapeutics (NASDAQ:TCRT) saw a significant stock increase of 34.9%, reaching $2.94, with a market value of $7.6 million. Other notable gainers included Senti Biosciences (NASDAQ:SNTI), which rose 17.62% to $0.31, and Picard Medical (AMEX:PMI), which increased by 11.99% to $11.2. Conversely, SciSparc (NASDAQ:SPRC) experienced the largest decline, falling 12.5% to $1.75, while MDxHealth (NASDAQ:MDXH) decreased by 11.4% to $0.53. https://www.openbell.ai/news/GP:1792098349253 2026-10-15T21:05:49.253Z daily 0.9 https://cdn.benzinga.com/files/images/story/2025/11/06/movers_3.jpg?width=250&height=187 12 Industrials Stocks Moving In Thursday's After-Market Session In Thursday's after-market session, GreenPower Motor (NASDAQ: GP) shares rose by 13.7% to $0.4, with a market value of $3.3 million. Other notable gainers included Bimergen Energy (AMEX: BESS), which increased by 8.22% to $2.5, and Perpetuals.com (NASDAQ: PDC), up 7.84% to $3.3. Conversely, TOMI Environmental Solutions (NASDAQ: TOMZ) saw a decline of 11.6% to $1.36, with a market value of $13.4 million. https://www.openbell.ai/news/HQ:1792098348868 2026-10-15T21:05:48.868Z daily 0.9 https://cdn.benzinga.com/files/images/story/2025/11/06/movers_4.jpg?width=250&height=187 12 Information Technology Stocks Moving In Thursday's After-Market Session During Thursday's after-market session, Horizon Quantum Holdings (NASDAQ: HQ) saw its shares rise by 7.5% to $14.99, with a market value of $782.9 million. Other notable gainers included Digi Power X (up 6.59% to $2.97) and Schmid Group (up 5.64% to $3.18). Conversely, NextTrip (NASDAQ: NTRP) experienced the largest decline, falling 13.2% to $1.45, while Zoom Communications (NASDAQ: ZM) decreased by 3.51% to $95.06, with a market cap of $28.6 billion. https://www.openbell.ai/news/SITC:1792098341642 2026-10-15T21:05:41.642Z daily 0.9 https://cdn.brandfetch.io/SITC/w/400/h/400?c=1idopYfmtR7ZKg8QMud SITE Centers Reveals Plan to De-list From NYSE; Co. Expects De-listing Before December 4, 2026 SITE Centers Corp. (NYSE: SITC) has announced its intention to voluntarily de-list its common shares from the New York Stock Exchange, expecting the de-listing to occur before trading begins on December 4, 2026. This decision is prompted by an anticipated special distribution payment on October 15, 2026, which may lead to a decrease in the trading price and market capitalization, potentially triggering involuntary de-listing. The company has not arranged for listing on another exchange or quotation medium. https://www.openbell.ai/news/VKTX:1792098341290 2026-10-15T21:05:41.290Z daily 0.9 https://cdn.brandfetch.io/VKTX/w/400/h/400?c=1idopYfmtR7ZKg8QMud UBS Initiates Coverage On Viking Therapeutics with Buy Rating, Announces Price Target of $94 UBS analyst Joon Lee has initiated coverage on Viking Therapeutics (NASDAQ: VKTX) with a Buy rating. The firm has set a price target of $94 for the stock. https://www.openbell.ai/news/SITC:1792098063508 2026-10-15T21:01:03.508Z daily 0.9 https://cdn.brandfetch.io/SITC/w/400/h/400?c=1idopYfmtR7ZKg8QMud SITE Centers Declares Special Cash Distribution Of $3.00 Per Common Share Payable Nov 5, 2026 openbell Financial News https://www.openbell.ai/news/SITC:1792097976222 2026-10-15T20:59:36.222Z daily 0.9 https://cdn.brandfetch.io/SITC/w/400/h/400?c=1idopYfmtR7ZKg8QMud SITE Centers Announces The Sale Of Its Interests In The Dividend Trust Portfolio Joint Venture For Net Proceeds Of ~$32.4M SITE Centers Corp. (NYSE: SITC) has announced the sale of its interests in the Dividend Trust Portfolio joint venture for net proceeds of approximately $32.4 million. Additionally, the Company's Board of Directors declared a special cash distribution of $3.00 per common share, payable on November 5, 2026, to shareholders of record as of October 27, 2026. https://www.openbell.ai/news/VNOM:1792097607843 2026-10-15T20:53:27.843Z daily 0.9 https://cdn.brandfetch.io/VNOM/w/400/h/400?c=1idopYfmtR7ZKg8QMud Scotiabank Initiates Coverage On Viper Energy with Sector Outperform Rating, Announces Price Target of $54 Scotiabank analyst Mark Lear has initiated coverage on Viper Energy (NASDAQ: VNOM) with a Sector Outperform rating. The firm has set a price target of $54 for the company's stock. https://www.openbell.ai/news/GME:1792097127595 2026-10-15T20:45:27.595Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/15/The-Gamestop-Logo-Is-Displayed-On-A-Smar.jpg?width=250&height=187 GME Stock Rally Fuels GMEU ETF Surge: One Technical Signal Could Change Everything The T-REX 2X Long GME Daily Target ETF (GMEU) rose by 5% due to increased interest in GameStop Corp. (GME), which reached a 52-week high of $28.22. GameStop shares are currently trading at $28.04, up 3.28% during regular trading. Despite strong short-term momentum, indicated by being 12.8% above its 20-day SMA and an RSI of 74.49, there are concerns about potential profit-taking or consolidation. GMEU's performance is amplified by its leverage, which can lead to significant gains or losses depending on GameStop's daily movements. https://www.openbell.ai/news/GOOG:1792096885358 2026-10-15T20:41:25.358Z daily 0.9 https://cdn.brandfetch.io/GOOG/w/400/h/400?c=1idopYfmtR7ZKg8QMud Google Rolls Out Universal Cart In U.S. Across Google Search, Gemini Google has launched its Universal Cart feature in the U.S., which integrates across Google Search and Gemini, enhancing the shopping experience for users. This rollout aims to streamline online shopping by allowing consumers to add items from various retailers into a single cart. The initiative is part of Google's broader strategy to strengthen its e-commerce capabilities and compete more effectively in the digital retail space. https://www.openbell.ai/news/SPCX:1792096821793 2026-10-15T20:40:21.793Z daily 0.9 https://cdn.brandfetch.io/SPCX/w/400/h/400?c=1idopYfmtR7ZKg8QMud 𝕏 Product Creator Allegra Jacchia Posts "We’re doubling down on video on 𝕏. Today, we're piloting Video Kickstart Bonus, an invite-only program that rewards creators for posting their video content here..." Allegra Jacchia, a product creator at 𝕏, announced the launch of the Video Kickstart Bonus program, which is an invite-only initiative aimed at rewarding creators for sharing video content on the platform. This move indicates 𝕏's strategic focus on enhancing video engagement and monetization. The program is part of a broader effort to strengthen the platform's content offerings and attract more creators. https://www.openbell.ai/news/INR:1792096792805 2026-10-15T20:39:52.805Z daily 0.9 https://cdn.brandfetch.io/INR/w/400/h/400?c=1idopYfmtR7ZKg8QMud Scotiabank Initiates Coverage On Infinity Natural with Sector Outperform Rating, Announces Price Target of $17 Scotiabank analyst Mark Lear has initiated coverage on Infinity Natural (NYSE: INR) with a Sector Outperform rating. The firm has set a price target of $17 for the stock. https://www.openbell.ai/news/DVN:1792096675824 2026-10-15T20:37:55.824Z daily 0.9 https://cdn.brandfetch.io/DVN/w/400/h/400?c=1idopYfmtR7ZKg8QMud Scotiabank Initiates Coverage On Devon Energy with Sector Outperform Rating, Announces Price Target of $61 Scotiabank analyst Mark Lear has initiated coverage on Devon Energy (NYSE: DVN) with a Sector Outperform rating. The firm has set a price target of $61 for the company's stock. https://www.openbell.ai/news/VOGX:1792096650455 2026-10-15T20:37:30.455Z daily 0.9 https://cdn.brandfetch.io/VOGX/w/400/h/400?c=1idopYfmtR7ZKg8QMud Vogenx Initiates EMERGE, Phase 2b Clinical Trial Evaluating Mizagliflozin For Treatment Of Post-Bariatric Hypoglycemia Vogenx, Inc. (NASDAQ: VOGX) has initiated the EMERGE Phase 2b clinical trial to evaluate mizagliflozin for treating post-bariatric hypoglycemia (PBH), a condition with no FDA-approved therapies. The trial will enroll about 36 adults who have undergone bariatric surgery and will assess the drug's safety, tolerability, and effectiveness in reducing hypoglycemic events. Participants will receive either 5 mg or 10 mg of mizagliflozin or a placebo over 28 days, with continuous glucose monitoring throughout the study. https://www.openbell.ai/news/XXII:1792096623494 2026-10-15T20:37:03.494Z daily 0.9 https://cdn.brandfetch.io/XXII/w/400/h/400?c=1idopYfmtR7ZKg8QMud 22nd Century Group shares are trading higher after the company announced that combined same-store retail unit sales of Pinnacle VLN and Pinnacle Pure increased 161% from Q2 to Q3. openbell Financial News https://www.openbell.ai/news/XXII:1792096428561 2026-10-15T20:33:48.561Z daily 0.9 https://cdn.brandfetch.io/XXII/w/400/h/400?c=1idopYfmtR7ZKg8QMud 22nd Century Group Reports 161% Increase In Sales In Q3 From Q2 For Combined Same-Store Retail Units Of Pinnacle VLN, Pinnacle Pure 22nd Century Group, Inc. (Nasdaq: XXII) reported a 161% increase in combined same-store retail unit sales of Pinnacle VLN and Pinnacle Pure from Q2 to Q3. This growth was attributed to increased consumer awareness and enhanced marketing efforts. The sales were recorded at a retail partner with approximately 1,500 outlets. https://www.openbell.ai/news/CNXU:1792096395629 2026-10-15T20:33:15.629Z daily 0.9 https://cdn.brandfetch.io/CNXU/w/400/h/400?c=1idopYfmtR7ZKg8QMud Conexeu Sciences Closes ~$5M Private Placement At $3.00/Unit With Warrants At $3.00/Share, Led By Existing Holders Including CEO openbell Financial News https://www.openbell.ai/news/CSWC:1792096351913 2026-10-15T20:32:31.913Z daily 0.9 https://cdn.brandfetch.io/CSWC/w/400/h/400?c=1idopYfmtR7ZKg8QMud Capital Southwest Reports Preliminary Fiscal Q2 2027 Net Investment Income Of $0.56-$0.57/Share, NAV Of $16.62-$16.67/Share openbell Financial News https://www.openbell.ai/news/CTW:1792096261676 2026-10-15T20:31:01.676Z daily 0.9 https://cdn.brandfetch.io/CTW/w/400/h/400?c=1idopYfmtR7ZKg8QMud CTW Cayman FY EPS $0.07 Misses $0.09 Estimate, Sales $82.509M Down From $90.371M YoY CTW Cayman (NASDAQ: CTW) reported quarterly earnings of $0.07 per share, missing the analyst consensus estimate of $0.09 by 22.22%. This represents a 16.67% increase from $0.06 per share in the same period last year. The company reported sales of $82.509 million, an 8.70% decrease from $90.371 million year-over-year. https://www.openbell.ai/news/MGY:1792096101569 2026-10-15T20:28:21.569Z daily 0.9 https://cdn.brandfetch.io/MGY/w/400/h/400?c=1idopYfmtR7ZKg8QMud Scotiabank Initiates Coverage On Magnolia Oil & Gas with Sector Outperform Rating, Announces Price Target of $31 Scotiabank analyst Mark Lear has initiated coverage on Magnolia Oil & Gas (NYSE: MGY) with a Sector Outperform rating. The firm has set a price target of $31 for the company's stock. https://www.openbell.ai/news/HAIN:1792095963098 2026-10-15T20:26:03.098Z daily 0.9 https://cdn.brandfetch.io/HAIN/w/400/h/400?c=1idopYfmtR7ZKg8QMud 'Wellness Company Hain Celestial Said to Eye Potential Bankruptcy' - Bloomberg Exclusive Hain Celestial, a wellness company, is reportedly considering potential bankruptcy as it faces financial difficulties. The company's stock, traded under the ticker HAIN, has been under pressure amid these challenges. Specific financial figures or strategic changes were not detailed in the article. https://www.openbell.ai/news/GPOR:1792095924960 2026-10-15T20:25:24.960Z daily 0.9 https://cdn.brandfetch.io/GPOR/w/400/h/400?c=1idopYfmtR7ZKg8QMud Scotiabank Initiates Coverage On Gulfport Energy with Sector Outperform Rating, Announces Price Target of $217 Scotiabank analyst Mark Lear has initiated coverage on Gulfport Energy (NYSE: GPOR) with a Sector Outperform rating. The analyst has set a price target of $217 for the company's stock. https://www.openbell.ai/news/AR:1792095838723 2026-10-15T20:23:58.723Z daily 0.9 https://cdn.brandfetch.io/AR/w/400/h/400?c=1idopYfmtR7ZKg8QMud Scotiabank Initiates Coverage On Antero Resources with Sector Outperform Rating, Announces Price Target of $46 Scotiabank analyst Mark Lear has initiated coverage on Antero Resources (NYSE: AR) with a Sector Outperform rating. The bank has set a price target of $46 for the company's stock. https://www.openbell.ai/news/FBIN:1792095825991 2026-10-15T20:23:45.991Z daily 0.9 https://cdn.brandfetch.io/FBIN/w/400/h/400?c=1idopYfmtR7ZKg8QMud Fortune Brands Innovations To Sell Fiberon Decking Business To Inteplast For $160M; Expects Additional Impairment Charge Of Up To $205M Fortune Brands Innovations, Inc. has agreed to sell its Fiberon decking business to Inteplast Group Corporation for $160 million in cash. Following a recoverability test, the company recorded a long-lived asset impairment of $221.2 million related to Fiberon, which included a reduction in the carrying value of customer relationships and property. Additionally, an expected non-cash impairment charge of $175 million to $205 million is anticipated due to the sale. https://www.openbell.ai/news/DJCO:1792095818668 2026-10-15T20:23:38.668Z daily 0.9 https://cdn.brandfetch.io/DJCO/w/400/h/400?c=1idopYfmtR7ZKg8QMud Daily Journal Acquires Revir Technologies; Financial Terms Undisclosed Daily Journal Corporation (NASDAQ: DJCO) has acquired Revir Technologies, a software company specializing in digital evidence management for law enforcement and public safety agencies. The acquisition, which closed on October 13, 2026, was funded with cash on hand, but financial terms were not disclosed. Revir will operate independently within Daily Journal's new Courts, Justice, and Government Technology division, alongside Journal Technologies, and is not expected to materially impact Daily Journal's financial condition or operations. https://www.openbell.ai/news/CHRD:1792095741590 2026-10-15T20:22:21.590Z daily 0.9 https://cdn.brandfetch.io/CHRD/w/400/h/400?c=1idopYfmtR7ZKg8QMud Scotiabank Initiates Coverage On Chord Energy with Sector Outperform Rating, Announces Price Target of $192 Scotiabank analyst Mark Lear has initiated coverage on Chord Energy (NASDAQ: CHRD) with a Sector Outperform rating. The firm has set a price target of $192 for the stock. https://www.openbell.ai/news/CBAN:1792095456489 2026-10-15T20:17:36.489Z daily 0.9 https://cdn.brandfetch.io/CBAN/w/400/h/400?c=1idopYfmtR7ZKg8QMud Colony Bankcorp And First Reliance Bancshares Jointly Announce Shareholders' Approval For Proposed Business Combination Colony Bankcorp, Inc. (NYSE: CBAN) and First Reliance Bancshares, Inc. (OTCQX: FSRL) have announced that shareholders from both companies have approved the merger, allowing First Reliance to become part of Colony. This strategic move is expected to enhance Colony's market position and operational capabilities. https://www.openbell.ai/news/FANG:1792095454838 2026-10-15T20:17:34.838Z daily 0.9 https://cdn.brandfetch.io/FANG/w/400/h/400?c=1idopYfmtR7ZKg8QMud Scotiabank Initiates Coverage On Diamondback Energy with Sector Outperform Rating, Announces Price Target of $250 Scotiabank analyst Mark Lear has initiated coverage on Diamondback Energy (NASDAQ: FANG) with a Sector Outperform rating. The firm has set a price target of $250 for the company's stock. https://www.openbell.ai/news/VRNS:1792095391125 2026-10-15T20:16:31.125Z daily 0.9 https://cdn.brandfetch.io/VRNS/w/400/h/400?c=1idopYfmtR7ZKg8QMud Varonis Systems Agrees To Be Acquired By Thoma Bravo's Proofpoint For ~$6.3B In Cash Varonis Systems, Inc. has entered into a definitive agreement to be acquired by Proofpoint, Inc., a Thoma Bravo portfolio company, for approximately $6.3 billion in cash. This acquisition marks a significant move in the data and AI security sector, as Varonis is recognized as a leader in this field. https://www.openbell.ai/news/SNTI:1792095348516 2026-10-15T20:15:48.516Z daily 0.9 https://cdn.brandfetch.io/SNTI/w/400/h/400?c=1idopYfmtR7ZKg8QMud Senti Biosciences shares are trading higher after the company announced it received stockholders' approval for its merger with ST NewCo. openbell Financial News https://www.openbell.ai/news/SRTA:1792095317709 2026-10-15T20:15:17.709Z daily 0.9 https://cdn.brandfetch.io/SRTA/w/400/h/400?c=1idopYfmtR7ZKg8QMud Third Point Says Acquired Strata Critical Medical's Securities For Investment Purposes And Believe That Common Stock Is "Undervalued" openbell Financial News https://www.openbell.ai/news/SRTA:1792095260240 2026-10-15T20:14:20.240Z daily 0.9 https://cdn.brandfetch.io/SRTA/w/400/h/400?c=1idopYfmtR7ZKg8QMud Third Point's Daniel Loeb Urges Strata Critical Medical To Explore Strategic Alternatives Including Potential Sale Daniel Loeb of Third Point has urged Strata Critical Medical (SRTA) to explore strategic alternatives, including a potential sale, due to concerns over the company's overhead not being supported by its current scale. The Reporting Persons believe the company's common stock is undervalued and plan to communicate with management and other shareholders regarding operational and governance matters. They may also consider purchasing additional shares or selling their current holdings based on future evaluations of the company's financial position and market conditions. https://www.openbell.ai/news/BTCUSD:1792095204880 2026-10-15T20:13:24.880Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/15/Bitcoin-Btc-Virtual-Cryptocurrency-In-Fr.jpg?width=250&height=187 Bitcoin Wins Whether AI Booms or Busts, Bitwise Exec Says: ‘All Roads Lead to Bitcoin’ Bitwise executive Matt Hougan asserts that regardless of the trajectory of the AI economy—whether it experiences a boom, bust, or remains stable—Bitcoin (CRYPTO: BTC) is positioned to rise. He outlines three potential scenarios: a superabundance driven by AI leading to increased demand for scarce assets like Bitcoin, a bubble burst resulting in initial declines but ultimately benefiting Bitcoin through government intervention, and a stable growth scenario where Bitcoin continues to attract investment. Hougan emphasizes that nearly all macroeconomic conditions favor Bitcoin's growth as a store of value. https://www.openbell.ai/news/JBHT:1792095172414 2026-10-15T20:12:52.414Z daily 0.9 https://cdn.brandfetch.io/JBHT/w/400/h/400?c=1idopYfmtR7ZKg8QMud J.B. Hunt Transport Services shares are trading lower after the company reported worse-than-expected Q3 EPS results. openbell Financial News https://www.openbell.ai/news/BZH:1792095070146 2026-10-15T20:11:10.146Z daily 0.9 https://cdn.brandfetch.io/BZH/w/400/h/400?c=1idopYfmtR7ZKg8QMud Beazer Homes Says Stockholders Approve Merger With Dream Finders Homes; Expects To Announce Completion Within Coming Days Beazer Homes announced that its stockholders have approved the merger with Dream Finders Homes. The company expects to announce the completion of the merger within the coming days. This strategic move is anticipated to impact the market positively as Beazer Homes continues to expand its operations. https://www.openbell.ai/news/INDB:1792095065890 2026-10-15T20:11:05.890Z daily 0.9 https://cdn.brandfetch.io/INDB/w/400/h/400?c=1idopYfmtR7ZKg8QMud Independent Bank Q3 Adj. EPS $1.90 Beats $1.84 Estimate, Sales $261.948M Beat $261.040M Estimate Independent Bank (NASDAQ: INDB) reported Q3 adjusted earnings per share of $1.90, surpassing the analyst estimate of $1.84 by 3.26%, and marking a 22.58% increase from $1.55 per share in the same quarter last year. The company's quarterly sales reached $261.948 million, exceeding the expected $261.040 million by 0.35%, and reflecting a 7.47% increase from $243.742 million in the prior year. https://www.openbell.ai/news/LCNB:1792095030448 2026-10-15T20:10:30.448Z daily 0.9 https://cdn.brandfetch.io/LCNB/w/400/h/400?c=1idopYfmtR7ZKg8QMud LCNB Q3 EPS $0.51 Beats $0.47 Estimate, Sales $25.020M Beat $24.500M Estimate openbell Financial News https://www.openbell.ai/news/NYXH:1792094905728 2026-10-15T20:08:25.728Z daily 0.9 https://cdn.brandfetch.io/NYXH/w/400/h/400?c=1idopYfmtR7ZKg8QMud Nyxoah Submits FDA Application To Expand Genio Indication To Complete Concentric Collapse Patients; Pivotal Data Show 74.3% Median Reduction In Apnea Events openbell Financial News https://www.openbell.ai/news/MGNX:1792094807378 2026-10-15T20:06:47.378Z daily 0.9 https://cdn.brandfetch.io/MGNX/w/400/h/400?c=1idopYfmtR7ZKg8QMud MacroGenics Doses First Patient In Phase 1 Study Of MGC030, Antibody-Drug Conjugate Directed Against Undisclosed Target, In Patients With Advanced Solid Tumors MacroGenics, Inc. (NASDAQ: MGNX) has announced the dosing of the first patient in a Phase 1 study of MGC030, a first-in-class antibody-drug conjugate targeting an undisclosed antigen in patients with advanced solid tumors. The study is designed to assess the safety, tolerability, pharmacokinetics, and preliminary antitumor activity of MGC030, with up to 54 participants expected in the dose escalation phase, which may expand further at selected dose levels. https://www.openbell.ai/news/CRWV:1792094738759 2026-10-15T20:05:38.759Z daily 0.9 https://cdn.brandfetch.io/CRWV/w/400/h/400?c=1idopYfmtR7ZKg8QMud CoreWeave’s Bonds Hit 15% Yield: This Analyst Still Sees 105% Upside For The Stock CoreWeave Inc. (NASDAQ: CRWV) has seen its bond yields rise to over 15%, indicating financial strain, while its stock price has fallen approximately 16% recently, sitting 65% below its May 2025 peak. Despite this, Bank of America maintains a Buy rating with a price target of $140, suggesting a potential upside of 105%. The bank has raised its revenue growth forecasts to 105% for 2027 and 63% for 2028, driven by increased capacity and pricing. However, concerns remain regarding CoreWeave's projected negative free cash flow and significant cash needs for upcoming years. https://www.openbell.ai/news/AVXL:1792094668092 2026-10-15T20:04:28.092Z daily 0.9 https://cdn.brandfetch.io/AVXL/w/400/h/400?c=1idopYfmtR7ZKg8QMud Anavex Life Sciences Receives FDA Clearance to Proceed Ahead With Its Planned Clinical Trial Under Its Investigational New Drug Application For ANAVEX 2-73 For Fragile X Syndrome Anavex Life Sciences Corp. has received FDA clearance to proceed with its clinical trial for ANAVEX 2-73 (blarcamesine) targeting Fragile X syndrome, a genetic condition with no FDA-approved treatments. The Investigational New Drug Application (IND) is now open, allowing for clinical investigation in the U.S. Blarcamesine has previously been granted Orphan Drug Designation by the FDA for this condition. https://www.openbell.ai/news/IBKR:1792094636989 2026-10-15T20:03:56.989Z daily 0.9 https://cdn.brandfetch.io/IBKR/w/400/h/400?c=1idopYfmtR7ZKg8QMud Interactive Brokers Raises Quarterly Dividend From $0.0875 To $0.15/Share openbell Financial News https://www.openbell.ai/news/CTNT:1792094564949 2026-10-15T20:02:44.949Z daily 0.9 https://cdn.brandfetch.io/CTNT/w/400/h/400?c=1idopYfmtR7ZKg8QMud Cheetah Net Says It Plans To Oppose Takeover Time 2026’s Consent Solicitation Seeking To Replace Its Board openbell Financial News https://www.openbell.ai/news/AVXL:1792094558611 2026-10-15T20:02:38.611Z daily 0.9 https://cdn.brandfetch.io/AVXL/w/400/h/400?c=1idopYfmtR7ZKg8QMud Anavex Life Sciences shares are trading higher after the company announced it has received notification from the FDA that the company may proceed with its planned clinical study under its Investigational New Drug Application for ANAVEX 2-73 for Fragile X syndrome. openbell Financial News https://www.openbell.ai/news/AVXL:1792094533002 2026-10-15T20:02:13.002Z daily 0.9 https://cdn.brandfetch.io/AVXL/w/400/h/400?c=1idopYfmtR7ZKg8QMud Anavex Life Sciences Receives FDA Clearance to Proceed Ahead With Its Planned Clinical Trial Under Its Investigational New Drug Application For ANAVEX For Fragile X Syndrome Anavex Life Sciences Corp. has received FDA clearance to proceed with its clinical trial for ANAVEX®2-73 (blarcamesine) under its Investigational New Drug Application for Fragile X syndrome, a genetic condition with no FDA-approved treatment. The IND is now open, allowing for clinical investigation in the U.S. Blarcamesine has also received Orphan Drug Designation from the FDA for this condition.